Bell's Palsy With a Duration of Greater Than 8 Weeks Treated With Multiwave Locked System Intervention
NCT: NCT05846217 · COMPLETED
Brief Summary
OBJECTIVE: To determine whether photobiomodulation therapy by class IV Multiwave Locked System laser treatment could relieve symptoms in patients with Bell's palsy with a duration of greater than 8 weeks. METHODS AND METHODS: This randomized controlled trial from May 2021 to April 2023. Patients were eligible who had Bell's palsy with a duration of greater than 8 weeks on out-patient department of otorhinolaryngology in Beijing Tongren Hospital. The photobiomodulation group received class IV Multiwave Locked System laser treatment for 3 times per weeks, a total of 6 months. The control group received the same Multiwave Locked System treatment procedure except the laser parameter. The primary outcome measures comprised House-Brackmann facial nerve grading system, Sunnybrook facial grading system, Facial Clinimetric Evaluation Scale. Secondary outcome measures comprised Electroneurography, Electromyography, and the Blink Reflex.
Frequently Asked Questions
What is Bell's Palsy With a Duration of Greater Than 8 Weeks Treated With Multiwave Locked System Intervention?
Bell's Palsy With a Duration of Greater Than 8 Weeks Treated With Multiwave Locked System Intervention is a clinical trial registered under NCT05846217. Current status: COMPLETED.
What is the status of NCT05846217?
The current status of NCT05846217 (Bell's Palsy With a Duration of Greater Than 8 Weeks Treated With Multiwave Locked System Intervention) is: COMPLETED.
When did Bell's Palsy With a Duration of Greater Than 8 Weeks Treated With Multiwave Locked System Intervention start?
Bell's Palsy With a Duration of Greater Than 8 Weeks Treated With Multiwave Locked System Intervention started on 2021-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.